158 related articles for article (PubMed ID: 8117535)
21. Inflammatory and toxic myopathies.
Dalakas MC
Curr Opin Neurol Neurosurg; 1992 Oct; 5(5):645-54. PubMed ID: 1327303
[TBL] [Abstract][Full Text] [Related]
22. Inclusion body myositis, muscle blood vessel and cardiac amyloidosis, and transthyretin Val122Ile allele.
Askanas V; Engel WK; Alvarez RB; Frangione B; Ghiso J; Vidal R
Ann Neurol; 2000 Apr; 47(4):544-9. PubMed ID: 10762172
[TBL] [Abstract][Full Text] [Related]
23. Newest pathogenetic considerations in inclusion-body myositis: possible role of amyloid-beta, cholesterol, relation to aging and to Alzheimer's disease.
Askanas V; Engel WK
Curr Rheumatol Rep; 2002 Oct; 4(5):427-33. PubMed ID: 12217248
[TBL] [Abstract][Full Text] [Related]
24. Cystatin C colocalizes with amyloid-beta and coimmunoprecipitates with amyloid-beta precursor protein in sporadic inclusion-body myositis muscles.
Vattemi G; Engel WK; McFerrin J; Askanas V
J Neurochem; 2003 Jun; 85(6):1539-46. PubMed ID: 12787072
[TBL] [Abstract][Full Text] [Related]
25. Immunocytochemical localization of ubiquitin in inclusion body myositis allows its light-microscopic distinction from polymyositis.
Askanas V; Serdaroglu P; Engel WK; Alvarez RB
Neurology; 1992 Feb; 42(2):460-1. PubMed ID: 1310532
[No Abstract] [Full Text] [Related]
26. Apolipoprotein E and apolipoprotein E messenger RNA in muscle of inclusion body myositis and myopathies.
Mirabella M; Alvarez RB; Engel WK; Weisgraber KH; Askanas V
Ann Neurol; 1996 Dec; 40(6):864-72. PubMed ID: 9007091
[TBL] [Abstract][Full Text] [Related]
27. Sporadic inclusion-body myositis: conformational multifactorial ageing-related degenerative muscle disease associated with proteasomal and lysosomal inhibition, endoplasmic reticulum stress, and accumulation of amyloid-β42 oligomers and phosphorylated tau.
Askanas V; Engel WK
Presse Med; 2011 Apr; 40(4 Pt 2):e219-35. PubMed ID: 21392932
[TBL] [Abstract][Full Text] [Related]
28. Inclusion body myositis (IBM).
Gayathri N; Anisya-Vasanth ; Veerendra Kumar M; Das S; Santosh V; Yasha TC; Ramamohan Y; Taly AB; Gourie-Devi M; Shankar SK
Clin Neuropathol; 2000; 19(1):13-20. PubMed ID: 10774946
[TBL] [Abstract][Full Text] [Related]
29. p62/SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion-body myositis muscle fibers, and can help differentiating it from polymyositis and dermatomyositis.
Nogalska A; Terracciano C; D'Agostino C; King Engel W; Askanas V
Acta Neuropathol; 2009 Sep; 118(3):407-13. PubMed ID: 19557423
[TBL] [Abstract][Full Text] [Related]
30. Ubiquitin immunostaining and inclusion body myositis: study of 30 patients with inclusion body myositis.
Prayson RA; Cohen ML
Hum Pathol; 1997 Aug; 28(8):887-92. PubMed ID: 9269823
[TBL] [Abstract][Full Text] [Related]
31. Amyloid-beta deposition in skeletal muscle of transgenic mice: possible model of inclusion body myopathy.
Fukuchi K; Pham D; Hart M; Li L; Lindsey JR
Am J Pathol; 1998 Dec; 153(6):1687-93. PubMed ID: 9846958
[TBL] [Abstract][Full Text] [Related]
32. Inclusion-body myositis and myopathies: different etiologies, possibly similar pathogenic mechanisms.
Askanas V; Engel WK
Curr Opin Neurol; 2002 Oct; 15(5):525-31. PubMed ID: 12351995
[TBL] [Abstract][Full Text] [Related]
33. Immunohistological study on the distribution of alpha 1-antichymotrypsin in Alzheimer's brain, compared to beta-amyloid precursor protein and beta-amyloid protein.
Takahashi H; Hirokawa K; Tsukagoshi H
J Neurol Sci; 1990 Nov; 99(2-3):301-10. PubMed ID: 2128319
[TBL] [Abstract][Full Text] [Related]
34. Activation of the Unfolded Protein Response in Sporadic Inclusion-Body Myositis but Not in Hereditary GNE Inclusion-Body Myopathy.
Nogalska A; D'Agostino C; Engel WK; Cacciottolo M; Asada S; Mori K; Askanas V
J Neuropathol Exp Neurol; 2015 Jun; 74(6):538-46. PubMed ID: 25978849
[TBL] [Abstract][Full Text] [Related]
35. Enhanced detection of congo-red-positive amyloid deposits in muscle fibers of inclusion body myositis and brain of Alzheimer's disease using fluorescence technique.
Askanas V; Engel WK; Alvarez RB
Neurology; 1993 Jun; 43(6):1265-7. PubMed ID: 8170582
[No Abstract] [Full Text] [Related]
36. Inclusion body myositis: abnormal protein accumulation does not trigger apoptosis.
Hutchinson DO
Neurology; 1998 Dec; 51(6):1742-5. PubMed ID: 9855538
[TBL] [Abstract][Full Text] [Related]
37. Ubiquitin and beta-amyloid-protein in inclusion body myositis (IBM), familial IBM-like disorder and oculopharyngeal muscular dystrophy: an immunocytochemical study.
Leclerc A; Tomé FM; Fardeau M
Neuromuscul Disord; 1993 Jul; 3(4):283-91. PubMed ID: 8268725
[TBL] [Abstract][Full Text] [Related]
38. Rimmed vacuoles with beta-amyloid and tau protein deposits in the muscle of children with hereditary myopathy.
Fidziańska A; Glinka Z
Acta Neuropathol; 2006 Aug; 112(2):185-93. PubMed ID: 16788822
[TBL] [Abstract][Full Text] [Related]
39. Ubiquitin expression in inclusion body myositis. An immunohistochemical study.
Albrecht S; Bilbao JM
Arch Pathol Lab Med; 1993 Aug; 117(8):789-93. PubMed ID: 8393651
[TBL] [Abstract][Full Text] [Related]
40. Muscle fiber degeneration in distal myopathy with rimmed vacuole formation.
Murakami N; Ihara Y; Nonaka I
Acta Neuropathol; 1995; 89(1):29-34. PubMed ID: 7709728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
